인슐린 주사기 시장 규모, 점유율 및 성장 분석 : 주사기 사이즈별, 질환 유형별, 최종 용도별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Insulin Syringes Market size was valued at USD 1.77 Billion in 2024 and is poised to grow from USD 1.85 Billion in 2025 to USD 2.57 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The escalating incidence of diabetes, predominantly type 2, significantly propels the global insulin syringes market, fueled by factors like sedentary lifestyles, unhealthy eating habits, urbanization, and rising obesity levels in both advanced and emerging economies. With millions reliant on insulin therapy, the demand for efficient and cost-effective delivery systems, such as syringes, is intensifying, especially in resource-limited settings where more advanced devices are inaccessible. Concurrently, major pharmaceutical companies are transitioning from older insulin delivery methods, like human insulin pens, to newer, high-margin treatments, ultimately reducing affordable options for patients in low- to middle-income regions. As a result, these populations are increasingly reverting to conventional insulin syringes, impacting demand positively within healthcare systems that lack support for more advanced technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Syringes Market Segments Analysis

Global Insulin Syringes Market is segmented by Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type and region. Based on Syringe Size, the market is segmented into 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1 CC Syringe (1ml) and Others. Based on Disease Type, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on End-Use, the market is segmented into Hospitals & Clinics, Homecare Settings and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on Needle Length, the market is segmented into Short, Medium and Long. Based on Product Type, the market is segmented into Standard Insulin Syringes and Safety Insulin Syringes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Syringes Market

The expanding global elderly population faces a heightened risk of diabetes, leading to an increased requirement for insulin. As the prevalence of age-related diabetes rises, the demand for insulin syringes continues to grow steadily. This surge is driven by the critical need for accurate and regular insulin injections to manage the condition effectively. Consequently, the market for insulin syringes experiences significant growth, fueled by the ongoing necessity to accommodate the escalating number of individuals requiring insulin therapy. The interplay between an aging demographic and diabetes management directly influences market dynamics, resulting in a robust demand for insulin administration devices.

Restraints in the Global Insulin Syringes Market

A significant challenge facing the global insulin syringes market is the reluctance of many patients to initiate or maintain insulin therapy due to fear of needles and the discomfort associated with injections. This apprehension leads to a decreased willingness to use syringes consistently, which adversely affects patient adherence to treatment regimens. Consequently, low compliance rates hinder the overall growth and expansion of the market, as effective diabetes management relies heavily on regular insulin administration. Addressing these psychological and physical barriers is crucial for improving patient acceptance and fostering a more robust market presence for insulin delivery devices.

Market Trends of the Global Insulin Syringes Market

The Global Insulin Syringes market is witnessing a significant trend towards miniaturization, with a growing demand for smaller insulin syringes, particularly those holding 0.5 ml. This shift is primarily driven by an increasing population of pediatric patients and individuals with Type 1 diabetes, who prioritize dosing accuracy and comfort. As manufacturers respond to these needs, the development of more compact and user-friendly syringes has emerged as a critical focus, enhancing patient compliance and overall health management. This trend not only reflects the evolving preferences of patients but also a broader commitment to improving diabetes care through innovative design solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis

Global Insulin Syringes Market Size by Syringe Size & CAGR (2026-2033)

• Market Overview
• 3/10 CC Syringe (0.3ml)
• 1/2 CC Syringe (0.5ml)
• 1 CC Syringe (1ml)
• Others

Global Insulin Syringes Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Insulin Syringes Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Homecare Settings
• Others

Global Insulin Syringes Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Insulin Syringes Market Size by Needle Length & CAGR (2026-2033)

• Market Overview
• Short
• Medium
• Long

Global Insulin Syringes Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Standard Insulin Syringes
• Safety Insulin Syringes

Global Insulin Syringes Market Size & CAGR (2026-2033)

• North America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • US
  • Canada
• Europe (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hindustan Syringes & Medical Devices Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott Pharma AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ApiJect Systems Corporation (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (U.K.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allison Medical Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations